Investor Atlas

2080 Ventures · Investor research

30 Series D investors targeting Norway

Compare 30 Series D investors targeting Norway. Review the selection, investor types and reported focus with 2080 Ventures.

30matching investors
0individual investors
30organizations

What this selection covers

This guide contains 30 distinct directory identities matching target markets: Norway; funding stages & types: Series D. Counts describe Investor Atlas coverage, not the size of the market or currently available capital.

“Targeting Norway” means the source explicitly lists this investment market. These investors may be headquartered elsewhere. Worldwide or regional labels are not expanded into individual countries.

Series D is a reported funding-stage or financing-type tag. Business milestones such as prototype or early revenue are kept separate.

Investor types represented: Venture Capital (29), Family Office (3), Corporate Venture Capital (1), Private Equity (1).

Common reported sector tags: SaaS (24), Fintech (20), Healthcare (20), AI & ML (17). Investors can have multiple tags.

Prepare a focused approach

Start with the sector and business model you operate in, then narrow by funding round, target market and investor type.

Before pitching for Norway, confirm incorporation requirements, team location and whether the mandate supports market entry or only established local operations.

For Series D, show the evidence already achieved, the next milestone and a budget connecting the raise to that milestone. Confirm expected round size and ownership.

  1. Check the current mandate and recent investments.
  2. Confirm check size, lead or follow preference, and company eligibility.
  3. Identify the relevant partner and published pitch route.
  4. Explain your customer evidence, raise and specific reason for approaching this investor.

Explore the 30 matching investors

Listed alphabetically, without ranking by performance or likelihood of investment. Full profiles, investment criteria and available contact details require sign-in.

InvestorInvestor typeResearch
Abingworth
Venture CapitalView profile ↗
Act Venture Capital
Venture CapitalView profile ↗
Advent Life Sciences
Venture CapitalView profile ↗
Amasia
Venture CapitalView profile ↗
Andreessen Horowitz
Venture CapitalView profile ↗
Arts Alliance
Family Office, Venture CapitalView profile ↗
Atomico
Venture CapitalView profile ↗
Balderton Capital
Venture CapitalView profile ↗
Blue Bear Capital
Venture CapitalView profile ↗
Bosch Ventures
Venture Capital, Corporate Venture CapitalView profile ↗
Creandum
Venture CapitalView profile ↗
Dawn Capital
Venture CapitalView profile ↗
Entrée Capital
Venture CapitalView profile ↗
EQT Ventures
Venture Capital, Family OfficeView profile ↗
Evolution Equity Partners
Venture CapitalView profile ↗
Global Founders Capital
Venture Capital, Family OfficeView profile ↗
HealthCap
Venture CapitalView profile ↗
Index Ventures
Venture CapitalView profile ↗
Industrifonden
Venture CapitalView profile ↗
Inveready
Venture CapitalView profile ↗
Kinnevik
Venture CapitalView profile ↗
Kleiner Perkins
Venture CapitalView profile ↗
MVM Life Science Partners
Venture CapitalView profile ↗
Northzone
Venture CapitalView profile ↗
Permira
Private EquityView profile ↗
Prime Ventures
Venture CapitalView profile ↗
RockPort Capital
Venture CapitalView profile ↗
Sequoia Capital
Venture CapitalView profile ↗
Target Partners
Venture CapitalView profile ↗
Ventech
Venture CapitalView profile ↗

How these guides are compiled. Source-reported criteria may change. A listing does not confirm current investment activity.